180 Life Sciences Corp.

Ownership Transactions Reported by 23 Insiders

Symbol
ATNF, ATNFW on Nasdaq
Industry
Pharmaceutical Preparations
Location
3000 El Camino Real, Bldg 4, Ste 200, Palo Alto, CA

Insiders trading volume in the past year

180 Life Sciences Corp. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Elray Resources, Inc. Former 10% Owner $4.18M -$9.28M -68.9% Jul 27, 2025
McAndrew Rudisill Chief Executive Officer, Director $2.76M Nov 12, 2025
Ryan Smith Director $2.05M Nov 12, 2025
Jason New Director $1.85M Nov 12, 2025
Blair Jordan Chief Executive Officer, Director $1.41M Aug 21, 2025
Crystal Heter Director $880K Nov 12, 2025
Andrew Suckling Director $718K Nov 12, 2025
Stephen H. Shoemaker Director $342K Aug 8, 2025
Lawrence Steinman Director $256K Jul 12, 2025
Marc Feldmann Director $47.2K Dec 28, 2023
Eric Van Lent Chief Accounting Officer $38.2K Jul 12, 2025
James N. Woody Chief Executive Officer, Director $12.6K Dec 15, 2023
Jay Goodman Director $12.2K Feb 20, 2025
Donald A. McGovern Jr. Director $10.4K Sep 4, 2023
Pamela Marrone Director $6.55K Sep 4, 2023
Jonathan B. Rothbard Chief Scientific Officer $5.27K Sep 4, 2023
Lawrence Marshall Gold Director $4.65K Sep 4, 2023
Russell T. Ray Director $4.59K Sep 4, 2023
Quan Vu COO / Chief Business Officer $3.85K Dec 16, 2021
Ozan Pamir Cfo $1.69K Sep 4, 2023
Teresa DeLuca Director $95.00 Sep 4, 2023
Francis Knuettel II Director Sep 4, 2023
Omar Jimenez Director Mar 7, 2024

Recent Insider Transactions by Companies or Individuals for 180 Life Sciences Corp.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.